Engineered Bacteria Churn Out Record Yields of Sustainable Isobutylamine

A team of metabolic engineers in Germany has coaxed the industrial workhorse bacterium Corynebacterium glutamicum into producing isobutylamine directly from sugar, achieving the highest microbial titer ever reported for any short-chain primary amine in minimal medium. Writing in Biotechnology for Biofuels and Bioproducts, researchers from Bielefeld University and the Technical University of Munich describe how a combination of pathway design, transport engineering and an unexpected lesson about cellular electricity pushed production to 33.2 grams per liter in a fed-batch bioreactor. The work offers a template for replacing a hazardous petrochemical process with a fermentation that runs on glucose, xylose and even food-industry waste.

Isobutylamine belongs to the short-chain primary amines, molecules carrying a reactive nitrogen group on an alkyl chain of one to seven carbons. These compounds are everywhere in modern chemistry: more than forty percent of small-molecule pharmaceuticals are amines, and the class serves as a precursor for herbicides, fungicides, insecticides and corrosion inhibitors. The aliphatic amine market was valued at roughly 3.8 billion US dollars in 2024 and is projected to grow to 5.7 billion by 2033. Today, nearly all of it is made by reductive amination of fossil-derived carbonyl compounds under harsh, energy-intensive and unsafe conditions. A biological route that works at neutral pH and thirty degrees Celsius, powered by renewable sugar, would be a meaningful step toward a circular chemical economy.

The German team’s strategy exploited a natural piece of biochemistry borrowed from an unlikely source. In the soil bacterium Streptomyces viridifaciens, the enzyme VlmD decarboxylates the amino acid L-valine during the synthesis of the antibiotic valanimycin, stripping a carboxyl group and releasing isobutylamine. The researchers codon-harmonized the vlmD gene for expression in C. glutamicum and first validated the enzyme in a crude extract assay, mixing E. coli lysate containing VlmD with twenty millimolar L-valine at pH 7 and thirty degrees. Isobutylamine appeared within 7.5 minutes, and after an hour the strongest extract had converted most of the substrate, yielding roughly 20.8 millimolar product and a specific activity of about 0.4 units per milligram. Decarboxylation reactions carry an inherent thermodynamic advantage because carbon dioxide bubbles out of the reaction, pulling the equilibrium toward product.

With the enzyme proven in vitro, the challenge became supplying enough L-valine inside living cells. The team built on three pyruvate-accumulating C. glutamicum strains previously developed in their laboratories. These strains decouple glycolysis from the tricarboxylic acid cycle by deleting or downregulating the aceE gene encoding the E1 subunit of pyruvate dehydrogenase, so that carbon flows toward pyruvate rather than acetyl-coenzyme A. Because pyruvate is the starting point for branched-chain amino acid biosynthesis, the researchers overexpressed the ilvBNCD operon, which channels pyruvate through acetolactate, dihydroxyisovalerate and ketoisovalerate to L-valine, and added the transaminase gene ilvE. Initial titers were modest, and feeding twenty millimolar L-valine to the cultures roughly tripled isobutylamine output, confirming that precursor supply was the bottleneck.

Two transport engineering strategies then unlocked the real gains. First, the team deleted brnFE, the genes encoding the exporter that normally pumps branched-chain amino acids out of the cell, cutting extracellular L-valine accumulation up to twentyfold. Second, they overexpressed brnQ, the importer gene, so that any valine that did leak out was pumped back in. The best shake-flask performer, an A16-P-derived strain carrying the valine biosynthesis plasmid, the decarboxylase and the importer, reached 165.7 millimolar isobutylamine, equivalent to 12.1 grams per liter, with a yield of 0.74 moles of product per mole of glucose. Notably, deleting the exporter and overexpressing the importer each helped, but combining them gave no additional benefit, suggesting both manipulations converge on the same goal of keeping valine inside the cell where VlmD can reach it.

The most surprising finding concerned a seemingly sensible addition that backfired. Because the step from ketoisovalerate to valine requires NADPH, the team had overexpressed pntAB from E. coli, a proton-translocating transhydrogenase that converts NADH into NADPH using the membrane potential as driving force. The same strategy had previously boosted isobutanol production in these strains. Here it did the opposite: isobutylamine titers collapsed. Using the fluorescent dye DiOC2(3) and flow cytometry, which reports membrane polarization through a red-to-green fluorescence shift, the researchers discovered that PntAB expression depolarized the membrane. The explanation lies in the decarboxylation chemistry itself. When VlmD converts L-valine to isobutylamine, a cytosolic proton is consumed, which hyperpolarizes the membrane. The cell apparently balances this by exporting the protonated amine in exchange for protons. PntAB drains the gradient that ATP synthase depends on, starving the cell of energy and throttling both growth and production.

The membrane potential measurements also revealed how the bacterium copes with the toxic product. Adding one hundred millimolar isobutylamine to wild-type cells immediately reduced the flow cytometry event rate and the fluorescence ratio, indicating that a sudden dose can kill cells by collapsing their transmembrane potential. Yet cultures grown from the start with fifty or one hundred millimolar isobutylamine actually showed increased, hyperpolarized membrane potentials, suggesting cells adapt when exposed gradually. The researchers propose that uncharged isobutylamine diffuses across the membrane and is reprotonated inside, consuming cytosolic protons, while export systems related to the Amt/Mep/Rh ammonium transporters may shuttle the protonated amine outward in antiport with protons. Identifying a dedicated isobutylammonium exporter, they suggest, could further improve tolerance and titer.

Demonstrating flexibility beyond glucose, the team equipped the best producers with xylose-utilizing genes from Xanthomonas and grew them on the lignocellulosic pentose and on orange peel hydrolysate, a food-processing waste stream containing both glucose and xylose. Production worked on both second-generation feedstocks, reaching 87 millimolar on pure xylose and 44.2 millimolar on hydrolysate, though below the 173.9 millimolar achieved on glucose. The authors attribute the shortfall to reduced NADPH supply from the pentose phosphate pathway on xylose and to inhibitory 5-hydroxymethylfurfural in the hydrolysate, whose detoxification also consumes NADPH. Process optimization of hydrolysate preparation and fermentation will be needed before waste-based production becomes industrially relevant.

The final scale-up test delivered the headline result. In a three-liter fed-batch bioreactor, the best strain produced 454 millimolar, or 33.2 grams per liter, of isobutylamine within 64 hours, with a yield of 0.47 moles per mole glucose and a volumetric productivity of 0.52 grams per liter per hour. The titer nearly tripled compared with shake flasks, showing the process benefits from controlled feeding and aeration. Byproducts were modest, mainly L-alanine and branched-chain amino acids, and only a nonsignificant amount of product escaped into the off-gas. The enzyme’s substrate promiscuity even allowed a proof-of-concept for 3-methylbutan-1-amine, the L-leucine-derived amine, when a feedback-resistant leucine biosynthesis gene redirected flux. The authors argue the decarboxylation concept can extend to other short-chain primary amines, provided tolerance engineering keeps pace with the growing toxicity of longer-chain products. For now, the record titer stands as evidence that amines once locked behind hazardous petrochemistry can be brewed sustainably in a fermenter.

Subject of Research: Metabolic engineering of Corynebacterium glutamicum for sustainable microbial isobutylamine production

Article Title: Metabolic engineering strategies for sustainable de novo isobutylamine production by Corynebacterium glutamicum

Article References: Prasun, T., Müller, S., Stegelmann, F., Blombach, B., & Wendisch, V. F. (2026). Metabolic engineering strategies for sustainable de novo isobutylamine production by Corynebacterium glutamicum. Biotechnology for Biofuels and Bioproducts, 19(1), Article 80. https://doi.org/10.1186/s13068-026-02831-w

Image Credits: AI Generated

DOI: 10.1186/s13068-026-02831-w

Keywords: Corynebacterium glutamicum, metabolic engineering, isobutylamine, short-chain primary amines, L-valine decarboxylase, VlmD, membrane potential, bioreactor fermentation, second-generation feedstocks, orange peel hydrolysate, bio-based chemicals, transport engineering